PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
13.68%
Cash & equivalents yoy growth 10-20% – strong liquidity improvement. Benjamin Graham might question if returns on this buildup are adequate. Examine short-term yields or reinvestment opportunities.
No Data
No Data available this quarter, please select a different quarter.
13.68%
Cash + STI yoy growth 10-20% – solid buildup of liquid resources. Benjamin Graham might ask if these funds are earning a reasonable return.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.59%
Growth 10-20% – strong increase in liquidity. Benjamin Graham would question if it's too reliant on credit or genuinely boosting solvency.
-11.93%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-88.66%
Declining other non-current assets simplifies the balance sheet. Seth Klarman would favor this reduction in complexity.
-8.29%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
13.10%
10-20% yoy – strong asset growth. Warren Buffett wants to see if these assets produce good ROA.
-14.12%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
2.34%
Up to 5% yoy – small increase. Howard Marks questions if operating cash flow adequately covers the new short-term debt.
No Data
No Data available this quarter, please select a different quarter.
14.12%
Growth 10-20% – healthy pipeline. Benjamin Graham checks that delivery costs won't erode margins.
-2.34%
Declining other current liabilities reduces near-term obligations. Benjamin Graham would see this as improving short-term financial position.
-12.65%
Declining current liabilities reduces short-term financial pressure. Seth Klarman would see this as improving liquidity position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-36.66%
Declining total non-current liabilities reduces long-term leverage risk. Benjamin Graham would see this as strengthening the balance sheet.
No Data
No Data available this quarter, please select a different quarter.
-14.12%
Declining total liabilities strengthens the balance sheet. Howard Marks would see this as reducing financial risk.
5.56%
Above 5% yoy – more significant share issuance. Philip Fisher demands a strong ROI or else it's dilution.
-2.30%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.36%
Equity growth ≥ 10% yoy – a strengthening net worth. Warren Buffett checks if the ROE is healthy.
13.10%
≥ 12% yoy – significant balance sheet expansion. Benjamin Graham checks if the new capital is productive.
No Data
No Data available this quarter, please select a different quarter.
-14.09%
Declining total debt reduces leverage risk. Seth Klarman would see this as improving financial stability and flexibility.
-14.00%
Declining net debt indicates improving liquidity or deleveraging. Howard Marks would see this as strengthening financial position.